|
1. Fyfe I. Parkinson disease: Dopamine receptor variants improve response to rasagiline in PD. Nat Rev Neurol 2016; 12(7): 372. 2. Behari M, Bhattacharyya KB, Borgohain R, Das SK,Ghosh B, Kishore A, et al. Parkinson's disease. Ann Indian Acad Neurol 2011; 14(Suppl 1): S2-6. 3. McGeer PL, McGeer EG. Inflamation and neuodegeneration in Parkinson's disease. Parkinsonism Related Disord 2004; 10 Suppl 1: S3-7. 4. Jankovic J. Parkinson’s disease: clinical features and diagnosis. J Neurol Neurosurg Psychiatry 2008; 799(4): 368–76. 5. Domellöf ME, Forsgren L, Elgh E. Persistence of associations between cognitive impairment and motor dysfunction in the early phase of Parkinson's disease. J Neurol 2013; 260(9): 2228-36. 6. Wurtman RJ. Personalized medicine strategies for managing patients with parkinsonism and cognitive deficits. Metabolism 2013; 62 Suppl 1: S27-9. 7. Aarsland D, Bronnick K, Williams-Gray C, Weintraub D, Marder K, Kulisevsky J, et al. Mild cognitive impairment in Parkinson disease: a multicenter pooled analysis. Neurology 2010; 75(12): 1062-9. 8. Somme JH, Molano Salazar A, Gonzalez A, Tijero B, Berganzo K, Lezcano E ,et al. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene. Parkinsonism Relat Disord 2015; 21(5): 494-9. 9. da Silva WC, Köhler CC, Radiske A, Cammarota M. D1/D5 dopamine receptors modulate spatial memory formation. Neurobiol Learn Mem 2012; 97(2): 271-5. 10. Kempadoo KA, Mosharov EV, Choi SJ, Sulzer D, Kandel ER. Dopamine release from the locus coeruleus to the dorsal hippocampus promotes spatial learning and memory. Proc Natl Acad Sci U S A 2016; 113(51): 14835-40. 11. Izquidero I, Da Cunha C, Rosat R, Jerusalinsky D, Ferreira MB, Medina JH. Neurotransmitter receptors involved in post-training memory processing by the amygdala, medial septum, and hippocampus of the rat. Behav Neural Biol 1992; 58: 16-26. 12. Dickerson BC, Eichenbaum H. The episodic memory system: neurocircuitry and disorders. Neuropsychopharmacology 2010; 35(1): 86-104. 13. Knowles WD. Normal anatomy and neurophysiology of the hippocampal formation. J Clin Neurophysiol 1992; 9(2): 252-63. 14. Martig AK, Mizumori SJ. Ventral tegmental area and substantia nigra neural correlates of spatial learning. Learn Mem 2011; 18(4): 260-71. 15. Bethus I, Tse D, Morris RG. Dopamine and memory: modulation of the persistence of memory for novel hippocampal NMDA receptor-dependent paired associates. J Neurosci 2010; 30(5): 1610-8. 16. Kosaka K, Yokoi T. Carnosic acid a component of rosemary (Rosmarinus officinalis L.) promotes synthesis of nerve growth factor in T98G human glioblastoma cells. Biol Pharm Bull 2003; 26(11): 1620-2. 17. Park SE, Kim S, Sapkota K, Kim SJ. Neuroprotective effect of Rosmarinus officinalis extract on human dopaminergic cell line, SH-SY5Y. Cellular Molecular Neurobiol 2010; 30(5): 759–67. 18. Bahri S, Jameleddine S, Shlyonsky V. Relevance of carnosic acid to the treatment of several health disorders: Molecular targets and mechanisms. Biomed Pharmacother 2016; 84: 569-582. 19. Fu MH, Li CL, Lin HL, Chen PC, Calkins MJ, Chang YF ,et al. Stem cell transplantation therapy in Parkinson's disease. Springerplus 2015; 4: 597. 20. Napoli E, Borlongan CV. Cell Therapy in Parkinson's disease: Host Brain Repair Machinery Gets a Boost from Stem Cell Grafts. Stem Cells 2017; 35(6): 1443-5. 21. Braun SM, Jessberger S. Adult neurogenesis and its role in neuropsychiatric disease, brain repair and normal brain function. Neuropathol Appl Neurobiol 2014; 40(1): 3-12. 22. Wang X, Wang Y, Gou W, Lu Q, Peng J, Lu S, et al. Role of mesenchymal stem cells in bone regeneration and fracture repair: a review. Int Orthop 2013; 37(12): 2491-8. 23. Friedenstein AJ, Chailakhjan RK, Lalykina KS. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet 1970; 3(4): 393-403. 24. Kim HJ, Park JS. Usage of Human Mesenchymal Stem Cells in Cell-based Therapy: Advantages and Disadvantages. Dev Reprod 2017; 21(1): 1-10. 25. Lee JS, Park JC, Kim TW, Jung BJ, Lee Y, Shim EK, et al. Human bone marrow stem cells cultured under hypoxic conditions present altered characteristics and enhanced in vivo tissue regeneration. Bone 2015; 78: 34-45. 26. Guilak F, Lott KE, Awad HA, Cao Q, Hicok KC, Fermor B, et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol 2006; 206(1): 229-37. 27. Gronthos S, Franklin DM, Leddy HA, Robery PG, Storms RW, Gimble JM, et al. Surface protein characterization of human adipose tissue-derived stromal cells. J Cell Physiol 2001; 189(1): 54-63. 28. Ferro MM, Bellissimo MI, Anselmo-Franci JA, Angellucci ME, Canteras NS, Da Cunha C. Comparison of bilaterally 6-OHDA- and MPTP-lesioned rats as models of the early phase of Parkinson's disease: histological, neurochemical, motor and memory alterations. J Neurosci Methods 2005; 148(1): 78-87. 29. McDowell K, Chesselet MF. Animal models of the non-motor features of Parkinson's disease. Neurobiol Dis 2012; 46(3): 597-606. 30. Da Cunha C, Angelucci ME, Canteras NS, Wonnacott S, Takahashi RN.The lesion of the rat substantia nigra pars compacta dopaminergic neurons as a model for Parkinson's disease memory disabilities. Cell Mol Neurobiol 2002; 22(3): 227-37. 31. Campos FL, Carvalho MM, Cristovão AC, Je G, Baltazar G, Salgado AJ, Kim YS, Sousa N. Rodent models of Parkinson's disease: beyond the motor symptomatology. Front Behav Neurosci 2013;7, 175-192. 32. Lee HJ, Lee JK, Lee H, Carter JE, Chang JW, et al. Human umbilical cord blood-derived mesenchymal stem cells improve neuropathology and cognitive impairment in an Alzheimer's disease mouse model through modulation of neuroinflammation. Neurobiol Aging 2012; 33(3): 588-602. 33. Girard SD, Devéze A, Nivet E, Gepner B, Roman FS, Féron F, et al. Isolating nasal olfactory stem cells from rodents or humans. J Vis Exp 2011; (54). pii: 2762. 34. Alkam T, Nitta A, Mizoguchi H, Itoh A, Nabeshima T. A natural scavenger of peroxynitrites, rosmarinic acid, protects against impairment of memory induced by Abeta (25-35). Behav Brain Res 2007; 180(2): 139-45. 35. Tsuji M, Miyagawa K, Takeuchi T, Takeda H. Pharmacological characterization and mechanisms of novel antidepressive and/or anxiolytic-like substances identified from Perilla Herba. Nihon Shinkei Seishin Yakurigaku Zasshi 2008; 28(4): 159-67. 36. Sozio P, Iannitelli A, Cerasa LS, Cacciatore I, Cornacchia C, Giorgioni G, et al. New L-dopa codrugs as potential anti-Parkinson agents. Arch Pharm (Weinheim). 2008; 341(7): 412-7. 37. Tamadoni M, HG Kashani M, Ghorbanian MT, Abrari K, Arashpour R. Neuroprotective effects of carnosic acid on the hippocampus of 6-hydroxydopamine injured rats. Koomesh 2014; 15(2): 232-41. 38. Qiao L, Hou L, Lu A, Feng M, Qian C, et al. Differentiation to neural-like cells, a potential application of mesenchymal stem cells based on traditional Chinese medicine theories. Stem Cell Res Therapeutics 2016; 1(1): 41-52. 39. Udalamaththa VL, Jayasinghe CD, Udagama PV. Potential role of herbal remedies in stem cell therapy: proliferation and differentiation of human mesenchymal stromal cells. Stem Cell Res Ther 2016; 7(1): 110. 40. Chen J, Li Y, Zhang R, Katakowski M, Gautam SC, Lu M, et al. Combination therapy of stroke in rats with a nitric oxide donor and human bone marrow stromal cells enhances angiogenesis and neurogenesis. Brain Res 2004; 1005(1-2): 21-8. 41. Nezhadi A, Ghazi F, Rassoli H, Bakhtiari M, Ataiy Z, Soleimani S, et al. BMSC and CoQ10 improve behavioural recovery and histological outcome in rat model of Parkinson’s disease. Pathophysiology 2011; 18(4): 317-24. 42. Brundin P, Karlsson J, Emgård M, Schierle GS, Hansson O, Petersén A. Castilho RF. Improving the survival of grafted dopaminergic neurons: a review over current approaches. Cell Transplant 2000; 9(2): 179-95.
|
.png)
.png){kind=logo}
